Viewing Study NCT00619268


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-02-25 @ 8:49 PM
Study NCT ID: NCT00619268
Status: COMPLETED
Last Update Posted: 2013-02-15
First Post: 2008-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma
Sponsor: Centre Leon Berard
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bevacizumab View
None Temsirolimus View
None Metastatic renal cell carcinoma View
None Non-progression View